Furthermore, high expression of MAZ predicted a poor OS and progression-free survival in PCa patients based on analysis of the PCa dataset from TCGA-PRAD (Additional file 1: Figure S1). The gene discussed is MAZ; the disease is posterior cortical atrophy.